Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.
about
Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureusInnate immune induction and influenza protection elicited by a response-selective agonist of human C5aPreliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.Complement in immune and inflammatory disorders: therapeutic interventions.A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.Immunomodulatory effects of recombinant lactoferrin during MRSA infection.
P2860
Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Control of methicillin resista ...... vel immunostimulatory peptide.
@ast
Control of methicillin resista ...... vel immunostimulatory peptide.
@en
type
label
Control of methicillin resista ...... vel immunostimulatory peptide.
@ast
Control of methicillin resista ...... vel immunostimulatory peptide.
@en
prefLabel
Control of methicillin resista ...... vel immunostimulatory peptide.
@ast
Control of methicillin resista ...... vel immunostimulatory peptide.
@en
P2093
P2860
P1433
P1476
Control of methicillin resista ...... vel immunostimulatory peptide.
@en
P2093
Celia M Ebrahimi
Courtney K Cavaco
Edward L Morgan
Kelly S Doran
Marilyn L Thoman
Sam D Sanderson
Tamsin R Sheen
P2860
P356
10.1016/J.VACCINE.2011.10.054
P407
P577
2011-10-30T00:00:00Z